☁️
Tiranë 17°C · Vranët 02 November 2026
S&P 500 7,580 ▼1.82%
DOW 51,770 ▼1.09%
NASDAQ 25,437 ▼2.86%
NAFTA 100.18 ▼3.78%
ARI 3,905 ▲0.15%
💱 VALUTAT
EUR/USD 1.1160 EUR/GBP 0.8335 EUR/CHF 0.9201 EUR/ALL 90.9858 EUR/MKD 61.4970 EUR/RSD 117.5272 EUR/TRY 55.7239 EUR/JPY 175.80 EUR/CAD 1.5587 EUR/USD 1.1160 EUR/GBP 0.8335 EUR/CHF 0.9201 EUR/ALL 90.9858 EUR/MKD 61.4970 EUR/RSD 117.5272 EUR/TRY 55.7239 EUR/JPY 175.80 EUR/CAD 1.5587
₿ CRYPTO
BTC $78,338 ▲ +0.14% ETH $2,300 ▲ +1.12% XRP $1.2553 ▲ +0.15% SOL $94.8000 ▼ -1.05%
S&P 500 7,580 ▼1.82 % DOW 51,770 ▼1.09 % NASDAQ 25,437 ▼2.86 % NAFTA 100.18 ▼3.78 % ARI 3,905 ▲0.15 % S&P 500 7,580 ▼1.82 % DOW 51,770 ▼1.09 % NASDAQ 25,437 ▼2.86 % NAFTA 100.18 ▼3.78 % ARI 3,905 ▲0.15 %
EUR/USD 1.1160 EUR/GBP 0.8335 EUR/CHF 0.9201 EUR/ALL 90.9858 EUR/MKD 61.4970 EUR/RSD 117.5272 EUR/TRY 55.7239 EUR/JPY 175.80 EUR/CAD 1.5587 EUR/USD 1.1160 EUR/GBP 0.8335 EUR/CHF 0.9201 EUR/ALL 90.9858 EUR/MKD 61.4970 EUR/RSD 117.5272 EUR/TRY 55.7239 EUR/JPY 175.80 EUR/CAD 1.5587
02 Nov 2026
Breaking
Technology

Neko Health, the Spotify billionaire’s body-scanning start-up, lands in the U.S.: nearly $1 billion in funding and 300,000 on the waiting list

Neko Health, the health start-up co-founded by Spotify billionaire Daniel Ek and Hjalmar Nilsonne, has landed in New York — the company’s first location in the U.S., as TechCrunch reports. The company has raised nearly $1 billion in funding in total and counts more than 300,000 people on its global waiting list.

The scan lasts about an hour and costs $500: it is not covered by health insurance, but according to TechCrunch it may qualify for payment through Health Savings Accounts. The check-up analyses blood, skin and metabolism with the help of advanced computer-vision technologies and artificial intelligence — the first generation of the scan measured 15 biomarkers, while today it measures 55.

As TechCrunch writes after speaking with Farooq Abbasi of Preface Ventures, an investor who has himself undergone the scan twice, Neko could become the future of preventive medicine in the U.S. In his view, preventive care should be cheap and accessible to everyone — precisely the model that Ek’s company promises.

However, the road ahead is not without challenges. TechCrunch notes that expanding operations and obtaining regulatory approvals in the United States remain two of the main obstacles Neko Health will have to overcome to turn the one-hour scan into a mass service.

Komentet

Bëhu i pari që komenton!

Lini një Koment të Ri

Për t'u përgjigjur një komenti specifik, kliko butonin 💬 Përgjigju poshtë atij komenti.

🔒 Komenti juaj do të publikohet pas miratimit nga moderatori.